Higher admission activated partial thromboplastin time, neutrophil-lymphocyte ratio, serum sodium, and anticoagulant use predict in-hospital COVID-19 mortality in people with Diabetes: Findings from Two University Hospitals in the U.K

Thomas Julian

doi:10.1016/j.diabres.2021.108955

Higher admission activated partial thromboplastin time, neutrophil-lymphocyte ratio, serum sodium, and anticoagulant use predict in-hospital COVID-19 mortality in people with Diabetes: Findings from Two University Hospitals in the U.K

Division of Evolution, Infection and Genomics

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Diabetes Research and Clinical Practice
DOIs	https://doi.org/10.1016/j.diabres.2021.108955
Publication status	Published - 14 Jul 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.diabres.2021.108955

Cite this

@article{a71fcef7a789464aa7866b60c9bfc957,

title = "Higher admission activated partial thromboplastin time, neutrophil-lymphocyte ratio, serum sodium, and anticoagulant use predict in-hospital COVID-19 mortality in people with Diabetes: Findings from Two University Hospitals in the U.K",

author = "Thomas Julian",

year = "2021",

month = jul,

day = "14",

doi = "10.1016/j.diabres.2021.108955",

language = "English",

journal = "Diabetes Research and Clinical Practice",

issn = "0168-8227",

publisher = "Elsevier BV",

}

Higher admission activated partial thromboplastin time, neutrophil-lymphocyte ratio, serum sodium, and anticoagulant use predict in-hospital COVID-19 mortality in people with Diabetes: Findings from Two University Hospitals in the U.K. / Julian, Thomas.
In: Diabetes Research and Clinical Practice, 14.07.2021.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Higher admission activated partial thromboplastin time, neutrophil-lymphocyte ratio, serum sodium, and anticoagulant use predict in-hospital COVID-19 mortality in people with Diabetes: Findings from Two University Hospitals in the U.K

AU - Julian, Thomas

PY - 2021/7/14

Y1 - 2021/7/14

UR - http://dx.doi.org/10.1016/j.diabres.2021.108955

U2 - 10.1016/j.diabres.2021.108955

DO - 10.1016/j.diabres.2021.108955

M3 - Article

SN - 0168-8227

JO - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

ER -

Higher admission activated partial thromboplastin time, neutrophil-lymphocyte ratio, serum sodium, and anticoagulant use predict in-hospital COVID-19 mortality in people with Diabetes: Findings from Two University Hospitals in the U.K

UN SDGs

Access to Document

Other files and links

Cite this